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ABSTRACT
Louis-Ferdinand, Robert Thomas, Ph.D. , University of Rhode Island
August, 1969. The Modification of Hepatic Microsomal Drug Metabolism by
Phenobarbital and Amphetamine. Major Professor: Dr. George C. Fuller.
This investigation was carried out to provide a mechanistic explanation
for the modification of hepatic microsomal drug metabolism produced by amphetamine· and phenobarbital.

The influence of phenobarbital administration

on the activity of microsomal ribonuclease during induction of drug-metabolizing
enzymes, was determined. Administration of phenobarbital (100 mg/kg) for
six days resulted in a significant (P .£0. 05) increase in hepatic microsomal
oxidative demethylation.

Conversely, hepatic microsomal ribonuclease activity

of phenobarbital-treated rats was significantly reduced to less than 5% of control
values. When phenobarbital (50 mg/kg) was administered for 5 days ribonuclease
activity was inhibited to about one-half of control values.

Phenolpthalein

{3-glucuronidase activity of hepatic microsomal fractions obtained from phenobarbital treated animals was not significantly (P) O. 05) different from controls.
Phenobarbital(lxlo-\1olar) did not inhibit ribonuclease activity following in vitro
additions to the assay system.

Time-response studies were. conducted following

the administration of a single dose of phenobarbital (100 mg/kg).

Results of

these studies indicated that microsomal p-chloro-N-methylaniline (PCMA)
demethylase stimulation and ribonuclease inhibition were temporaily related,
except for a 24 hour lag in the PCMA demethylase response.

Administration of

phenobarbital (50 mg/kg twice-daily) produced significant inhibition of ribonuclease and stimulaticn of drug metabolism in liver microsomes of intact,
adrenalectomized or hypophysectomized rats. Administration of 3-methylcholanthrene (40 mg/kg) to male rats resulted in a non-significant inhibition
of ribonuclease activity while p-nitroanisole demethylation was stimulated
three-fold. In vitro recombination experiments in which 105, 000 x g rat liver
supernatants from control and treated animals were combined ·with rnicrosomes

v
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I. INTRODUCTION
Since the duration of action of many drugs is determined by the rate
of hepatic drug-metabolism, (Conney, 1967) the pharmacological stimulation
or inhibition of drug biotransformation is a mechanism responsible for many
drug interactions.

This thesis includes two independent investigations; one is

designed to elucidate the mechanism of action of a drug which stimulates
hepatic drug metabolism (Phenobarbital).
The phenomenon of enzyme induction (increased amount of enzyme) has
long been a subject of interest to biochemists because of the key role this
phenomenon plays in metabolism. However, the precise mechanisms involved
in the regulation of many inducible enzymes are poorly understood. In addition
to the apparent pharmacological significance of such a phenomenon, it is
probable that investigations into the nature of the enhancement of drug-metabolizing systems can yield information relating to the general problem of the mechanism
of substrate-induced synthesis of an organized multienzyme system.
After the first report of induction of hepatic microsomal drug metabolism
(Brown et al. , (19 54) numerous investigators have demonstrated that the activity
of microsomal enzymes can be markedly influenced by the exposure of mammalian
or non-mammalian organisms to a variety of foreign compounds (Conney, 1965).
The enzyme inducers most frequently studied, phenobarbital (Pb) and 3-methylcholanthrene (MC) reportedly increase enzyme levels through enhanced de

~

protein synthesis (Kato et al., 1965; Conney, 1956) following augmented DNAdependent RNA synthesis (Gelboin et al., 1967; Wilson et al., 1967). However,
alternate explanations may be considered since microsomal protein may
accumulate independently of enhanced protein synthesis (Barnhard, 1969) through
stabilization of pre-existing protein (Kenny, 1967; Rechcigl, Jr., 1968).

This

argument is strengthened by the observation that Pb treatment will stabilize
liver microsomal enzyme protein (Shuster and Jick, 1966) and phospholipid
(Orrenius and Ericsson, 1966; Holtzman and Gillette, 1966).

5

6

Messenger RNA turnover rate has been suggested as a potential control
site in protein synthesis (Tomkins et al., 1969; Lawford and Schachter, 1966)
or hormone action (0 'Malley, 1969).

Conceivably, increased messenger RNA

availability for translation into enzyme protein may result from increased
DNA-dependent RNA synthesis and or reduced messenger RNA degradation.
Accordingly it may be postulated that enzyme inducers may increase liver
microsomal protein content due to reduced protein or RNA degradation as
well as via increased protein synthesis subsequent to enhanced RNA synthesis
or both.
This investigation was undertaken to examine the role of microsomal
ribonuclease in the induction of microsomal drug-metabolizing enzymes by
Pb and 3M C. Microsomal ribonuclease activity was examined during Pb
induction in intact, adrenalectomized and hypophysectomized rats to determine
whether intact adrenal or pituitary glands were required for suppression of
ribonuclease activity.

~vitro

e:x.--periments were designed to detect the

presence of inhibitors of ribonuclease activity in livers of Pb-treated rats.
The second investigation described herein examines the mechanism of
action of one of the known inhibitors of drug metabolism(amphetamine) (Lal,
et al., 1970).

The advisability of amphetamine administration to antagonize

barbiturate depression may be questioned due to the recent finding of several
investigators (Lal, et al., 1970; Weiss and Laties, 1964; Rushton and
Steinberg, 1963). Amphetamine administration results in inhibition of hexobarbital metabolism (Lal, et.al., 1970) and, as may be predicted, potentiation of
barbiturate activity (Weiss and Laties, 1964; Rushton and Steinberg, 1963).
This section describes kinetic studies which have been performed using in vitro
systems in order to determine a mechanistic basis for the potentiation of barbiturate action by administered amphetamine.

II.

LITERATURE SURVEY
Drug Metabolism

The duration and intensity of drug action is, for many agents inversely
proportional to the rate at which the therapeutic agent may be removed from
the body. Since many drugs must be metabolized to inactive metabolites
prior to excretion, drug metabolism and its alteration has become an important therapeutic and pharmacologic consideration which has attracted a
considerable amount of research attention. Numerous studies have shov..n that
the majority of drugs are metabolized by few reactions, and that the enzyme
systems which catalyze this metabolism are present in the endoplasmic reticulum of the liver (Claude, 1969).
The term microsome refers to the isolated form of the endoplasmic
reticulum when this cytoplasmic constituent is obtained by differential centrifugation (Claude, 1969). Microsomal enzymes obtained from mammalian
livers, catalyze a number of oxidations of which the reactions of oxidative
drug metabolism (N-dealkylation, 0-dealkylation, side chain oxidation, deamination and aromatic hydroxylation) are only a part (Greene, 1968). Early investigations have established that the enzymic oxidative metabolism of drugs is carried
out by enzymes located in the microsomal fraction of the liver while the system
which generates required NADPH can be fotmd in the soluble fraction.

Oxygen

is also a necessary co-factor (Conney, 1967).
The requirement for both NADPH and oxygen is consistent with the postulate
(Conney, 1967) that NADPH provides reducing equivalents for reduction of
cytochrome P-450 in liver microsomes. The reduced P-450 is thought to form
an "active oxygen" complex and the oxygen in the complex is then transferred
to the drug substrate (Conney, 1967).

7
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Stimulation of Drug Metabolism

Effect of Inducing Agents

~

ProtE?in Synthesis.

An inducing agent may be defined as a compound which enhances enzyme
activity by increasing the concentration of enzyme

protein~

Conney, 1967).

Considerable evidence exists to support the hypothesis that enhancement of
drug-metabolizing enzyme(DME) activity by phenobarbital(Pb) or 3-methylcholanthrene(MC) is mediated through stimulation of protein synthesis. Administration of Pb stimulates amino acid incorporation into liver microsomal
protein in vivo (Kato, et al. , 196 5) and in vitro(Jondorf et al. , 1966; Kato,

~

!!:.!.: ,

1966). The stimulation of amino acid incorporation and increase in microsomal
enzyme activity following MC or Pb administration may be prevented by administration of actinomycin-D (Gelboin and Blackburn, 1964; Orrenius, 1964) an
inhibitor of transcription (Reich,

~al.

, 1961). The administration of inhibitors

of translation such as ethionine(Conney, 1960) or puromycin(Conney, 1963) will
also prevent the induction of DME by either Pb or MC.
Effect of Inducing Agents on Phopholipid.
The importance of suppressed degradation in increasing the levels of
microsomal protein and phospholipid during Pb induction is controversial.
Pb treatment is reported to stimulate the rate of incorporation of inorganic
phosphate into microsomal phospholipid(Ernster and Orrenius, 196 5; Orrenius
~al.,

196 5). These results may be an indication of increased synthesis of phos-

pholipid s which accumulate in livers of Pb-treated rats (Ernster and Orrenius,
1965). Holtzman and Gillette(l966) have demonstrated, however, that increased
liver microsomal phospholipid in Pb-treated rats results from inhibition of
phospholipid degradation. Stein and Stein (1969) have arrive'd at similar conclusions after observing that Pb treatment results in the inhibition of acylphosphohydrolase (EC. 3. 6.1. 7) activity without stimulation of choline or etha.nolamine incorporation into microsomal phospholipid.

9

Tsukada and Lieberman (1965) suggest that microsomal phospholipid may
stabilize polyribosomes sine phospholipase (EC. 3. 1.1. 4) treatment of
polyribosomes results in inhibition of in vitro amino acid incorporation and
marked polyribosomal disaggregation.
Effect of Inducing Agents on Microsomal Protein Degradation.
It has been postulated that the accumulation of liver microsomal protein

following Pb treatment results from both a decreased rate of breakdown and
an increased rate of synthesis. In support of this hypothesis Shuster and
Jick (1966) demonstrated that Pb treatment reduces the rate of loss of incorporated tritiated leucine radioactivity from microsomal protein, to
one-half that observed in controls. In addition, no loss of radioactivity from
purified pre-labeled mouse liver NADPH Cytochrome c reductase (EC. 1. 6. 99.1)
was observed following Pb induction (Jick and Shuster, 1966) suggesting a
complete lack of degradation of the enzymes. Enzyme stabilization in the
presence of cycloheximide inhibited protein synthesis has been reported by
Kenny {196 7).

Loss of radioactivity from tyrosine-transaminase (E c. 2. 6. 1. 5)

occurs at a slower rate in cycloheximide-treated rats relative to untreated
controls.
These findings are in contrast with those of Holtzman (1969) Schimke et al.,
(1968) and Arias et al., (1969) who have failed to demonstrate stabilization of
14
microsomal protein by Pb in experiments utilizing c-guanidino-arginine, a
non-reutilized amino acid. Shirnke and collaborators compared the effect of
14
Pb on microsomal isotope retention using c-guanidino-arginine or tritiated
leucine as labels. They were able to demonstrate decreased release of label
when leucine was used to pre-label microsomal protein, follo>ving Pb treatment.
14
However, when
C-guanidino-arginine was used no evidence of membrane
3
protein stabilization by Pb could be demonstrated. The retention of H-leucine
was attributed to an increased degree of isoto.pe reutilization in the Pb treated
animal.

However, T. Omura at a recent meeting of the International Symposium

10

on microsomes and drug oxidations, at Tubingen; as reported by Schenkman
14
(1970) described studies indicating that c-guanidino-arginine-labeled microsomal
protein degradation is inhibited by Pb.
Thus, it is evident that the precise role of microsomal protein degradation in the mediation of Pb induction of DME remains unclear.
Other Post-Translational Mechanisms.
Evidence exists to support a hypothesis that post-translational controls
are operative during induction of microsomal DME systems. Reduction of
levels of any rate-limiting component during induction will interfere with the
enhancement of synthesis of metabolically active protein.

6

·-Aminolevulinic

acid synthetase induction by Pb was demonstrated by Marver (1969) who
suggested this as a means of providing the additional heme required for
increased synthesis of microsomal cytochromes. Administration of heme
inhibits Pb induction of

S -aminolevulinic acid synthethase and DME activity

and interferes with development of tolerance to hexobarbital (Marver, 1969).
3-Amino-1, 2, 4-triazole inhibits rat hepatic

b

-aminolevulinic acid dehydratase

(EC. 4. 2.1. 24) which catalyzes the second step involved in heme biosynthesis
(Baron and Tephly, 1969). These authors demonstrated that 3-amino-1,2, 4triazole inhibited Pb induction of cytochrome P-450 and inhibited Pb stimulation of ethylmorphine, or 3-methyl, 4-monoethylaminobenzene metabolism
(Baron and Tephly, 1969). However, no effect was observed on Pb stimulation
of NADPH-cytochrome c reductase activity in animals pretreated with 3-amino1, 2, 4-triazole (Baron and Tephly, 1969). While these data suggest that posttranslational control of Pb induction may exist, the possibility that these inhibitors may interfere with other limiting factors required for induction of
DME, has not been excluded at this time.
Effec! of Inducing Agents on RNA Synthesis.
The stimulation of hepatic protein synthesis by Pb or MG is postulated
to involve enhancement of DNA-directed RNA synthesis. Administration of
100 mg/kg of either Pb or MC stimulates nuclear RNA polymerase (as detei·mined

11

by incorporation of radioactive cytidine triphosphate into RNA) of isolated
rat liver nuclei within 3-20 hours (Wilson, et al., 1967; Gelboin ~al., 1967; Nebert
and

Gelboin, 1969). MC stimulation of RNA polymerase (EC. 2. 7. 7. 6)

of isolated rat liver nuclei is consistent with reported stimulation of orotic
acid-

14

c uptake into nuclear

RNA 3 hours after injection of MC (Leob and

Gelboin, 1964). Bresnick and Mosse (1969) have demonstrated that MC administration results in increased template activity of nuclear chromatin. In
these studies HNA synthesis was catalyzed by purified Micrococcus lysodeicticus RNA polymerase.

Furthermore, nearest-neighbor frequency

analyses of newly synthesized RNA indicate that this RNA is different from
RNA synthesized from control preparations (Bresnick and Madix, 1969;
Bresnick ~al., 1969).

As previously mentioned, the administration of

actinomycin-D prevents the stimulation of benzpyrene hydroxylase activity
by MC (Gelboin and Blackburn, 1964). These data indicate that MC induces
liver DME through genomic activation, resulting in increased DNA-dependent
RNA synthesis followed by enhanced synthesis of DME.
Different mechanisms may be involved during Pb induction.

Chromatin

isolated from Pb-treated rats directs synthesis of RNA with similar nearestneighbor frequencies to control preparations (Bresnick and Madix, 1969).
Actinomycin-D in doses close to the LD

50

(Philips~

al., 1960) inhibits but

does not completely prevent stimulation of enzyme activity produced by five
doses of Pb (Ernster and Orrenius, 1965; Orrcnius and Ernster, 1964). Three-

fold increases in DME activity are produced by Pb when actinomycin-D is
given simultaneously for 5 days as opposed to 4. 2 fold increases in DME
produced by Pb alone.
Administration of an RNA polymerase inhibitor which has been characterized

by

Wilson

et al., (1967); Gelboin, (1966) viz., A1--:atoxin B ,

does not inhibit Pb induction of DME (Kato, et al., (1969).

1

These authors

have also demonstrated that Pb will induce tolerance to hexobarbital in the
presence of aflatm."in
. B1 .

12

Thioacetamide is a carcinogen which increases nuclear size (Nluramatsu
and Busch, 1962) and produces ·marked (8-10 fold) increases in latent nuclear
ribonuclease activity and reduces cytoplasmic RNA content (Villabos ~al.,
1964; 1965; Busch, 1965). Thioacetamide prevents the increases in microsomal N-demethylase and cytochrome P-450 content usually associated with
Pb induction, however, thioacetamide has little effect on the enhancement of
drug metabolism resulting from MC administration (Sladek and Mannering,
1969; Mannering et al., 1969).
Enhancement of RNA polymerase has been reported in Pb treated
adrenalectomized rats but not Pb treated hypophysectomized rats (Nebert and
Gelboin, 1969; Wilson et al., 1967). However, it is well-established that Pbstimulation of microsomal amino acid incorporation (Jondorf et_&., 1966) and
induction of DME by Pb is not abolished by hypophysectomy (Conney, 1961).
Thus, in hypophysectomized rats, Pb-stimulation of RNA polymerase does
not appear to. play a major role in the induction of Dl\IE.
Evidence for Role of Ribonuclease.
Several investigators (Tomkins et al., 1969; Bresnick, 1967; O'Malley,
1969) have postulated that messenger RNA stabilization might be involved in
enzyme induction.

Control of RNA lifetime by RNase could conceivably operate

as a key factor in control of protein synthesis (Barnard, 1969).
Distribution studies of rat liver ribonuclease (RJ.'{ase) indicate that RNase
is widely distributed among particulate and non-particulate subcellular fractions
(De Duve, 1955; Rahman, 1967). Approximately 26-50 percent of total cellular
RNase is found in rat liver microsomal and soluble fractions.

Rat liver ribo-

nuclease activity components may be characterized by pH optima as follows:
pH 6. 0 (RNase I), pH 7. 8 (RNase II), (Roth, 1954) and, pH 9. 5 (RNase III)
(Rahman, 1967). Acid RNase (RNase I) is localized in the lysosomal fraction
along with other acid hydrolases while alkaline RNase has a somewhat wider
distribution and is potentially in close contact with R:N"A

(Kraft~

al., 1969).

13

An inverse relationship between RNase activity and RNA synthesis has
been suggested by the finding of several workers. Reduced incorporation of
label into RNA occurs in the presence of increased RNase activity (Meisler
and Tropp, 1969). These authors also demonstrated that stimulation of in
vitro RNA synthesis by deoxycholate or ammonium sulfate was correlated
with inhibition of nuclear RNase. Similarly, Wilson et al. , (1967) demonstrated
that in the presence of added RNase negligible RNA polymerase activity
3
(determined by cytidine- n triphosphate incorporation into RNA) is observed.
Further, Sarkar (1969), using a system induced by pretreatment with Triamcinolone observed an inverse correlation between liver RNase activity and
RNA content.
Increased RNase activity in vitro has been shown to inhibit
incorporation into rat liver microsomes

14

c-leucine

(Sto~e

and Joshi, 1962). Addition of
14
RNase to bacterial cell-free protein synthesizing systems inhibits
c-phenyl-

alanine incor.p oration into ribosomal protein by 99% (Scheinbuks ~al., 1969).
Inhibition of in vitro protein synthesis by RNase appears to be due to
increased degradation of messenger RNA followed by polysomal disaggregation.
Barondes and Nirenberg (1962) and Igarashi (1969) have reported that added
synthetic messenger can be rapidly degraded in cell-free protein synthesizing
systems before significant polymerization of amino acids can be detected.
Blobel and Potter (1966) have postulated that polysomal structure is highly
sensitive to RNase since exposed interribosomal messenger RNA segments
are more readily available for digestion by RNase than are protein-protected
ribosomal RNA. Utsunomiya and Roth (1966) compared relative stabilities of
ribosomal and non-ribosomal RNA by determining the origin of acid-soluble
RNA degradation products in incubation media containing non-ribosomal RNA
32
and P-labeled ribosomes. These authors demonstrated th at ribosomal RNA
was not significantly degraded to acid soluble products by RNase associated
with ribosomal particles.
Recent findings of Schlaeger et al. (1969) are in contrast with earlier
studies which suggested an inverse relationship between polyribosome stability

14

and RNase activity. Schlaeger and collaborators treated tumor cells with
2, 3, 5-tris (ethylene imino)-1, 4-benzoquinone (trenimon) to induce RNase
activity and were unable to demonstrate any reduction in stability of polysomes isolated from tumor cells as cellular RN ase activity as increased.
However, these authors failed to demonstrate that the polyribosomes isolated
from treinimon-treated cells were actually capable of supporting protein
synthesis or that RNase associated with polyribosomes isolated from teinimontreated cells actually contained increased RNase activities.
In vitro recombination studies comparing amino acid-incorporating
activity of cell-free systems derived from rat or chicken livers have demonstrated that chicken liver cell sap contains markedly elevated levels of RNase
activity (Siler and Fied, 1968). These studies have shown that incubation of
rat liver microsomes with chicken cell sap

r~sults

in marked inhibition of

polyuridylic acid-directed phenylalanine incorporation related to increased
degradation of polyuridylic acid.

Conversely, incubation of chicken liver

microsomes with rat liver cell sap results in amino acid incorporation which
is equivalent to that observed in incubations of rat supernatant and rat microsomes. These findings are consistant with those of Roth (1962) who has reported that an endogenous RNase inhibitor which is found in livers of rats,
mice and hamsters, is absent in chicken liver.

It is reasonable to conclude

that the diminished protein synthetic ability of chicken liver microsomes
associated with increased RNase activity is a function of messenger RNA
destruction.

Thus, the presence of high RNase activity would be expected to

decrease the response of an inducing agent which stimulates enzyme synthesis.
It has been demonstrated that while nikethimide induction of rats produces

tolerance to pentobarbital, nikethimide pretreatment of chickens does not reduce
the effect of subsequent pentobarbital treatment (Brazda ~al., 1965). DDT reduces
dieldrin storage in the rat but not in the chicken (Street et al., 1966). These
results are consistent with the concept that induction of DME is more difficult
in the presence of marked increases in RNase activity.

15

Modification of RNA Degradation During Enzyme Induction.
Administration of

14

c-indoleacet~c acid to green pea stem segments

results in initiation of growth and increased labeling of RNA (Bedana and
Galston, 1965), RNA fractions extracted from treated stem segments are
more resistant to RNA degradation than those extracted from untreated
control preparations. During cortisone induction an inverse relationship
has been demonstrated (Barnabei and Ottolenghi, 1968) between activity of
rat liver microsomal RNase and RNA polymerase. A similar inverse
relationship between RNA polymerase and microsomal RNase after cortisone
treatment has been reported (Terner et al., 1967). Sarkar et al., (1969) have
demonstrated a reduction of rat liver acid (EC. 2. 7. 7 .16) and alkaline RNase
(EC. 2. 7. 7.17) activity during triamcinolone treatment which could be correlated
with increases in aspartate and alanine aminotransferase activities.
Hormones have been shown to alter tissue RNase activity. Augmented
RNA levels have been correlated with decreased adrenal RNase following
corticotrophin administration to rats. This suppression of adrenal RNase
activity could be correlated with increased amounts of RNase inhibitor
(Imrie and Hutchison, 196 5). Brewer et al., (1969) reported two-fold increases in alkaline RN ase in postmitochondrial supernatant fractions prepared
from hypophysectomized rats.

They also reported that administration of

growth hormone resulted in the reduction of RNase activity to control levels.
The half-life of deoxythymidine kinase messenger RNA is doubled in
regenerating rat liver compared to controls (Bresnick, et al., 1967). These
authors postulate that hepatectomy results the elaboration of a substance which
prolongs mRNA half-life by inactivating RNA catabolism.

Inhibition of RNA

degradation in regenerating liver may be attributable to increased amounts of
endogenous RNase inhibitors which accumulate in regenerating rat liver
(Russell and Snyder, 1969; Tsukada, 1969; Shortman, 1962).
Thus much experimental evidence suggest that RNA levels and protein
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synthesis are influenced by RNase activity. Altered RNA degradation appears
to be part of the total cellular response to certain drugs and hormones as well
as ·experimental procedures which result in or otherwise affect induction of
enzyme protein.
Physiological Control of Ribonuclease Activity; Mechanisms.
Several potential control mechanisms have been implicated in the
literature or otherwise indicated as physiological control mechanisms of RNA
degradation.
A)

The more obvious among these are:

Compartmentation of enzyme (or subtrate) such as occurs with lysosomal
concentration of acid RNase (Kraft, et al., 1969).

B)

Endogenous inhibitors of RNase such as cations (Lamana and Mallette,
1949) polyamines (Busch, 1965) or protein RNase inhibitors (Gribnau
et al., 1970; Roth, 1962; Shortman, 1961; 1962).

C)

Steric inaccesibility ofRNA to degradation by RNase e.g. ribosomal RNA
protection (Utsunomiya and Roth, 1966) (Castle and Singer, 1965).

D)

Combination of hormone with RNA resulting in stabilization of hormoneRNA complex (Bedana and Galston, 196 5) or prevention of ribosomal
attachment to RNA resulting in enhancement of RNA degradation (Tomkins
et al., 1969).
Inhibition of Drug Metabolism
The clinical administration of amphetamine in cases of barbiturate

poisoning is based on tre expected antagonism of barbiturate activity by this
stimulant. However, recent findings that amphetamine will potentiate barbi.turate activity in certain instances suggest that this practice may be illadvised.
Rushton and Steinberg (1963) have demonstrated that simultaneous administration of "amobarbitone and d-amphetamine resulted in potentiation of
the effects of "amobarbitone" on rat motor activity. Weiss and Laties (1964)
demonstrated that combinations of pentobarbital. and amphetamine potentiated
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pentobarbital effects on dog behavioral activity. Such potentiation of
barbiturate activity may be attributable to amphetamine interference
with barbiturate biotransformation. Reports of interference with drug
metabolism involving amphetamine and methylphenidate (a related phenethylamine derivative) have appeared in the recent literature.
Methylphenidate inhibits imipramine metabolism in mouse liver where
imipramine hydroxylation predominates and in rat liver where demethylation
is themajor route of imipramine biotransformation (Perel

et~·,

1969).

Similarly, d-amphetamine metabolism which presumably involves p-hydroxylation (Axelrod, 1954) by perfused rat liver, is inhibited by desipramine
(Dingel and Bass, 1969). Lal et al., (1970) have demonstrated that amphetamine
inhibits mouse liver hexobarbital oxidase following in vivo administration or
in vitro addition of amphetamine to incubation mixtures. These results appear
to contrast with those of Kato et al., (1964); Kato and Chiesara (1962) and
Kato and Vassanelli (1962) who failed to demonstrate any effect cf amphetamine
administration on the response of rats to subsequent administration of meprobamate or"phenobarbitone." However, Kato and collaborators pretreated rats
with amphetamine 48 hours prior to testing while Lal and co-workers administered
amphetamine 1 hour before testing.
Inhibition of drug-metabolism occurs competitively in the presence of
alternative substrates of microsomal DME (Rubin et al., 1964). It is reasonable
to expect that since amphetamine is para hydroxylated by the rat in vivo
(Axelrod, 1954), amphetamine inhibition of drug metabolism may be attributed
to competition by an alternative substrate. However, d-amphetamine is not
metabolized by rat liver microsomes (Groppetti and Costa, 1965) or rat liver
10, 000 x g supernatant fractions (Dingel and Bass, 1969). These findings
suggest that an investigation of the kinetics of amphetamine inhibition of drug
metabolism by liver supernatant fraction may contribute to a better understanding of the mechanisms involved in similar drug-drug interactions.

III. EXPERilv1ENTAL

Animals
Male and female Sprague-Dawley rats obtained from Charles River
Breeding Laboratories (Wilmington, Mass.) weighing between O. 1-0. 5 kg
were used t hroughout the course of these studies.

The rats were maintained

on commer cial laboratory chow and water ad libitum in a room with controlled
temperature and alternating 12-hour periods of light and darkness. All drugs
were administered via the intraperitoneal route. Adrenalectomies and Hypophysectomies were performed by Charles River Breeding Laboratories.
Materials
Analytical reagent grade chemicals or equivalent were used throughout
these studies.

Cofactors (NADP, glucose-6-phosphate, p-chloroaniline , p-

chloro-N-:methylaniline, glucose-6-phosphate dehydrogenase (EC #1.1.1. 49)
and highly polymerized yeast RNA) were obtained from Calbiochem. Los Angeles, .
Calif. and crystalline bovine serum albumin was obtained from Armour Laboratories.

Drugs used were obtained from their respective manufacturers.

Preparation C1f Rat Liver Supernatant Fractions For Kinetic Studies.
Femafo {250-300 gm) and Male (325-348 gm) rats were decapitated.
Livers were perfused with ice-cold 0.15M KCl and were homogenized in 2 vol.
of ice-cold O. lM phosphate (pH7. 4) buffer for 1 min in a coaxial homogenizer.
The 9000 x g supernatant fraction was obtained by centrifugation at

o0 c (10, 000

rpm in an Model B-60 International Preparative Ultracentrifuge (I.E. C.) #874
rotor) for 30 min.
Preparation .of Rat Liver Supernatant Fractions.
Adult male rats were fuillotined following overnight fast.

Their livers were

perfused in situ with ice-cold 0. 251\1 sucrose and were homogenized with a
coaxial homogenizer at 1000 RPM for one minute with 3-5 volumes of ice-cold
0. 25M sucrose.

Homogenates were centrifuged at 14, 000 x g for 15 min at
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o0 c

in I.E. C. preparative ultracentrifuge and the resulting supernatant was

centrifuged at 105, 000 x g for 2 hours at

o0 c.

The 105, 000 x g pellet was

rinsed and dispersed in 0.25M sucrose and stored at -20°c until assayed.
Analytical Procedures
Determination of Microsomal Demethylation

'2! Aminopyrine.

Microsomal demethylation of aminopyrine was determined by assaying
for formaldehyde formed as described by McMahon and Easton (1962). The
incubation medium (5 ml) for aminopyrine demethylation contained aminopyrine
10 µMoles, NADP 2 µMoles, Mg Cl

50 µMoles, 0. 8 ml 105, 000 x g super2
natant from control animals, O. 2 ml microsomal suspension (approximately
6 mg protein) and 1 ml 0.1 M phosphate buffer pH 7. 4.

Parallel incubation

flasks containing 1. 32 µMoles of formaldehyde (standard) in place of substrate
and distilled water (blank) in place of substrate were carried through the entire
procedure.

Flasks were incubated in a Dubnoff shaker at. 37°C under air for

30 m,in. At the end of the incubation perioo flask contents were poured into
centrifuge tubes.

Four ml of 10% zinc chloride (prepared with co -frce water)
2
were .a dded and the tubes were mixed. Two ml of a saturated solution of barium
hydroxide were added and the samples were mixed again. The samples were
centrifuged for approximately 10 min and 5. 0 ml aliquots of clear supernates
were transferred to glass tubes containing 2. 0 ml of double-strength Nash
reagent (0. 04 M acetylacetone in 0. 4 M ammonium acetate-0. l M acetic acid).
The contents were mixed and the tubes were heated in a water bath at 60°c for
30 min. Absorbance was determined on a Beckman DB-G grating spectrophotometer at 410 rnµ, and the values were corrected for color of the blank. Amount
of formaldehyde formed was determined by comparison with absorbance of
standards .
Determination of P-Chloro-N-Methylaniline Demethylation.
Demethylation of p-chloro-N -methylaniline (PCMA) was determined
by assaying for p-chloroaniline formed according to the procedure of Kupfer
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and Bruggeman (1966) as modified by Fuller et al., (1969). Incubations
were carried out at 37° C under air for 30 min in m edia which contained
3 µ.Moles PCMA, 1. 6 µ.Moles NADP, 16 µ.Moles glucose-6-phosphate,
30 µ.Moles Mg Cl , 20 µ.Moles nicotinamide, 5 IU glucose-6-phosphate
2
dehydrogenase, 120 µ.Moles phosphate buffer (pH 7. 4) and 14, 00 x g rat
liver supernatant (2-4 mg) protein.

The reaction was stoppe d by the

addition of 3. 0 ml p-dimethylaminobenzaldehyde (20 mg/ml lN H so )
2 4
solution. Incubation fl.ask contents were mixed and centrifuged at 8000 x g
for 30 min.

Colors read on a Beckman DB-G grating spectrophotometer at

445 mµ. were corrected for color of blanks. Amount of p-chloroaniline formed
was determined by comparison with standards.
For kinetic studies PCMA demethylation was determined as described
above with the following modifications. Incubations were carried out at 37°C
~nder

air in media containing 0. 2 ml 9000 x g supernatant protein (6. 6-7. 4 mg

protein) equivalent to approximately 100 mg liver; 1. 6 µ.Moles NADP, 16 µ.Moles
glucose-6-phosphate, 30 µ.Moles MgC1 , 20 µ.Moles nicotinamide, 150 µ.Moles
2
phosphate buffer (pH 7. 4) and PCMA (6, 4, 5, 3 or 1. 5 µ.Moles) in a total volume
of 2 ml. Six µ.Moles d-amphetamine sulfate was used.
· Determination of

Phenolpthalein-~-Glucuronidase

Activity.

Phenolpthalein-{J-glucuronidase activity associated with microsomal
fractions was determined by assaying for phenolpthalein formed from phenolpthalein glucuronide according to the procedure of Talalay et al. (1946).
Incubations were carried out in a dubnoff shaker for 15 min at 37° C. Incubation media contained 5 µ.l microsomal suspension (0. 2 mg protein). 0. 5 ml
phenolpthalein-{J-glucuronide (2 mg/ml in O. 2 M acetate buffer (pH 5. 2)
solution, 0. 5 ml deionized water, 4. 0 ml O. 2 M pH 5. 2 acetate buffer. Parallel
incubations containing 50 µ.g phenolpthalein (standard) in place of substrate and
distilled water (blank) in place of substrate were carried through the entire procedure.
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At the end of the incubation period 5. 0 ml 4M glycine (adjusted to pH
10. 7 with NaOH) was added to the fl.asks and the contents were centrifuged
for 15 min in a clinical centrifuge. Absorbances read on a Beckman DB-G
grating spectrophotometer at 545 mµ were corrected for color of blanks.
The amount of phenolpthalein formed was determined by comparison with
the standard.
Determination of P-Nitroanisole Demethylase Activity.
P-Nitroanisole demethylase activity associated with microsomal fractions
was determined by assaying for p-nitrophenol formed according to a modification of the procedure of Netter and Seidel (1964). Incubations were carried
out at 37° C under air for 30 min in a medium containing 3 µMoles p-nitroanisole,
2 µMoles NADP, 20 µMoles glucose-6-phosphate, 80 µMoles nicotinamide,
120 µMoles Mg c1 , 5 IU glucose-6-phosphate dehydrogenase microsomal pro2
tein (2-3 mg) and 1 ml 0.1 molar phosphate (pH 7. 9) buffer in a total volume
of 3. 9 ml.
At the end of the incubation period 10 ml ice-cold acetone was added to
the incubation flasks.

One ml 0. 5 M glycine (adjusted to pH 9. 5 with NaOH)

was added. After centrifugation the supernatant was read a,gainst the tissue
blank at 410 mµ on a Beckman DB-G grating spectrophotometer. Amount of
p-nitrophenol formed was determined by comparison .with standard p-nitrophenol
solutions.
Determination of Ribonuclease Activity.
Ribonuclease activity of microsomal fractions was determined by assaying
for the acid-ethanol-soluble degradation products of highly· polymerized RNA,
according to a modification of the procedure of Tsukada (1969).

Incubations

were carried out at ·37°c under air for 20 min in a medium containing 0.2 ml
O. 2 M Tris-HCl buffer pH 7. 6, 1 mg highly polymerized yeast RNA and micro-

somal protein (0. 5-1 mg). At the end of the incubation period 1. 0 ni lM HCl
in 76% ethanol was added as a precipitant and the mixture was shaken thoroughly.
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The soluble fraction was separated by centrifugation at 10, 000 RPM at
in the #874 rotor of the I.E. C. preparative ultracentrifuge for 15 min.

o0 c
The

absorbance of 1 ml of the clear supernatant after dilution with 2-5 ml distilled
water was read at 260 mµ vs distilled water using a Beckman DB-G grating
spectrophotometer. Readings obtained were corrected for absorbances of
individual tissue and RNA blanks.
Estimation of Protein
Protein content was determined by the colorimetric procedure of Lowry
et al., (1951) with minor modifications. An aliquot (0.1 ml) of microsomal
suspension was added to 15 ml test tubes containing 10 ml of 0. 5 M sodium
hydroxide . The tubes were heated in a water bath until dissolution was complete.
Standard solutions of crystalline bovine serum albumin and a blank consisting
of 0. 2 5 M sucrose were carried through the entire procedure. When the tissue
was dissolved a O. 5 ml aliquot was removed and placed into a second tube containing 1 ml of O. 5M sodium hydroxide solution.

Five ml of reagent 'A' (pre-

pared by the addition of 1. 0 ml 1% cupric sulfate solution plus 1. 0 ml of 2. 7%
potassium tartrate to 100 ml of 2% sodium carbonate solution) was added to
each tube, mixed, and the tubes were allowed to stand at room temperature
for 20 min. At this time 0. 5 ml reagent 'B' (prepared by diluting commercial
Folin-phenol reagent vvith an equal volume of distilled water) was added to each
sample.

The samples were allowed to stand at room temperature for 40 min to

develop color. Absorbance at 500 mµ of the solutions was determined against
the blank in a Beckman DB-G grating spectrophotometer.
Statistical Methods
The students' "t" test calculated on an Olivetti Underwood Programma
101 was used to test for differences between means throughout this study.
formula employed is as follows:

The
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t

=

where:

s

p

2 =

Nl =

N + N - 2
2
1
Control sample size
s2 2

N2 =

Treated sample size

x1

2
s1 =

Control sample variance

~

=

Treated sample variance

=

Control sample mean
Treated sample mean

The degrees of freedom were taken as N + N - 2
1
2
The levels of P: were taken from Appendix 3 (Spiegel, 1961)
Calculation of Kinetic Constants
The data obtained from kinetic studies was statistically analyzed using
an IBM linear regression computer program entitled 'Boing'. The formula
used is as follows:
y

A 0 + AiX
(

~ Y) ( ~

N £ XY -

x2) - ( ~

X) ( 5" XY)

( ~X) ('LY)

where:
Xand Y

=

the reciprocals of the substrate concentration and
velocities respectively.

N

number of substrate concentrations employed.

y

=
=

Ai

=

Km/V
(where Km is the Michaelis constant and
V
Tsanie maximum velocity).
max

x
Ao

1/observed velocity (or 1/µMoles of p-chloroaniline/
min/mg protein).

1/substrate concentration (or 1/mMolar p-chloro-Nmethylaniline concentration.

=

!/maximum velocity (or 1/V
).
max
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The inhibition constant (Ki} was calculated on the basis that the slope of a
double reciprocal (1/v vs. 1/s) plot is altered by the factor (1 + i/Ki) in
the presence of a competitive inhibitor (Mahler and Cordes, 1966).
where i

inhibitor concentration

and K·l

inhibitor constant
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was given to controls. The animals were killed on day 5 and liver microsomal
fractions prepared from these animals were assayed for aminopyrine demethylase and RNase activity.
The effects of two doses of Pb (50 mg/kg and 2 5 mg/kg twice daily
for 4 days) on microsomal aminopyrine demethylase and RNase of intact adrenalectomized and hypophysectomized rats were qualitatively similar (Table 2).
In all groups except one, Pb significantly increased aminopyrine demethyla-

tion and reduced microsomal RNase activity. In each experiment, Pb treatment of hypophysectomized and adrenalectomized rats resulted in less
stimulation of aminopyrine demethylation or inhibition of RNase than that
observed in intact rats. An inverse correlation between the Pb stimulation
of aminopyrine demethylation and inhibition of microsomal RNase was
observed in all experiments.
In order to determine whether the observed differences in ribonuclease

were due to differences in the degree of lysosomal contamination, liver microsomal fractiorn from Pb-treated (50 mg/kg 5 days) and control animals were
assayed for ,B-glucuronidase activity which is localized in the lysosomal
fraction of rat liver (DeDUve, 1955).Phenolpthalein-,B-glucuronidase activity of
microsomal fractions obtained from Pb-treated animals was not significantly
(P >0. 05) different from controls thereby indicating that differential lysosomal
contamination was not a factor in the reduction of RNase activity of Pb-treatedrat microsomes (Table 3).
Since differences (described earlier in this thesis) exist between the
characteristics of MC and Pb induction of DME, the following experiment .was
designed to determine the effect of MC induction on RNase activity of microsomal
fractions. MC (40 mg/kg) was administered to male rats for two days.
Controls received the vehicle (corn oil). The animals were killed on the
third day and microsomal fractions prepared from these animals were
assayed for p-nitroanisole demethylase and RNase activity.
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Table 2
Inhibition of Ribonuclease During Phenobarbital Induction of
Microsomal Hepatic Drug-Metabolism in Intact. Adrenalectomized and Hypophysectomized Male Ratsa

Treatment (N)

Aminopyrine
demethylaseb
Mean :!: S. E.

Ribonuclease c
Mean + S. E.

Liver Microsomal
Protein mg/gm
liver ~ S. E. (N)

INTACT RATS
Control (6)

+
59. 8 - 2. 9

o. 230 ~ o. 027

+
21.0-0.82

Phenobarbital
25 mg/kg (5)

+
d
91.2 - 4.7

o. 105 +- o. 021 d

27.1~2.9

Phenobarbital
50 mg/kg (6)

100. 5 +
- 2. 9 d

o. 068

+
-

o. 008 d

+
d
28.1 - 1. 4

ADRENALECTOMIZED
Control (6)

50. 2 ~ 1. 9

+
.
0.161 - 0. 019

19. 9 ~ 0. 9

Phenobarbital
25 mg/kg (5)

+
d
65. 4 - 2. 5

0.114 ~ 0. 020NS

+
d
24.0_l.7

Phenobarbital
50 mg/kg (11)

+
d
69.9-3.0

o. 102 ~ o. 01od

+
26.0_l.1

Control (6)

HYPOPHYSECTOMIZED
48. 0 -+ 1. 3
0. 364 ~ o. 050

15.7~1.3

Phenobarbital
25 mg/kg (5)

68. 6 +
- 2. 5d

0.150 +
- o. 014d

2 4 .1 -+ 1.9 d

Phenobarbital
50 mg/kg (8)

68.7±5.od

0.147 :!: o. 050d

26.2~1.4d

aForty-five day old intact (170-200 gm), adrenalectomized (150-200 gm) and
hypophysectomized (100-120 gm) male rats received phenobarbital twice
daily for 4 days and were sacrificed on day 5. Adr-enalectomized and Hypophysectomized rats were used 2 weeks after operations.
bExpressed as mµMoles formald ehyde formed/30 min/mg microsomal protein.
CExpressed as optical density units at 260 mµ/20 min/mg microsomal protein.
dsignificantly different from respective controls
NSNot significantly different from control (p

<™· 05).

> O. 05)
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Table 3
Phenolpthalein-{3-Glucuronidase Activity of Microsomal
Fractions Obtained from Livers of Normal and PhenobarbitalTreated Ratsa
{3-Glucuronidaseb
Mean :!:" S. E. (N)

Control

43. 2 ~ 1. 2

(5)

Phenobarbital

46.0 ~ 4.7c

(4)

aValues represent means ~ standard error of determinations from controls
and rats (375-410 gm) treated with phe~obarbital (50 mg/kg) for 5 days.
bExpressed as mµMoles phenolpthalein formed/mg protein/15 min.
cNot significantly different from control (P ~ O. 05).
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Two-day MC treatment (40 mg/kg) resulted in a significant (P~ O. 05)
three-fold stimulation of microsomal p-nitroanisole demethylation one day
after termination of treatment (Table 4).

However, this three-fold stimulation

of microsomal p-nitroanisole demethylation is associated with a non-significant (P>O. 05) inhibition of RNase activity with this inducing agent.
In Vitro Recombination Studies.
Microsomes and 105, 000 x g supernatant fractions obtained from control
and Pb-treated rats were recombined to determine the presence of any endogenous inhibitors of RNase (Table 5 and Table 6). Negligible RNase activity
was found in supernatants from either control of Pb-treated animals. Incubation of control supernatants with microsomes from Pb-treated rats
resulted in a 17 percent stimulation of RNase activity.

Conversely, when mi-

crosomes from untreated animals were incubated with supernatants from
Pb-treated animals, control microsomal RNase activity was inhibited by 30
percent and 87 percent of control values in the two experiments (Table 5,
Table 6).
Repetition of these experiments in the presence of p-chloromercuri-6
benzoate (10 M) which is reported to inactivate the rat liver RNase inhibitor
characterized by Shortman (1962) resulted in 33-132 percent stimulation of
RNase in the incubation mixture composed of microsomes and supernates
prepared from Pb-treated animals (Table 6). In the incubation mixture
composed of PCMB, control supernatant and control

microsomal prepara-

tions 26 percent inhibition of RNase activity as observed. Addition of pchloromercuribenzoate to control microsomes incubated in the presence of
Pb supernatant increased RNase by 13 percent but not to control levels.
Boiled 105, 000 x g supernatant from Pb-treated rats were still able to inhibit
RNase activity of control microsomes.
In vitro addition of concentrations of Pb as high as 1 x 10.not influence RNase activity of microsomal fractions.

2

molar did

Caffeine, barbital
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Table 4
Comparison of Effect of Induction by 3-Methylcholanthrene on
Hepatic Microsomal P-Nitroanisole Deme thylase Activity and
Ribonuclease

Treatment (N)

P-Nitroanisole
Demethylasea
Mean ~ S. E.

Ribonucleaseb
Mean : S. E.

Control (5)

3. 46 ~ 1. 52

o. 302

3-Methylcholanthrene
(40 mg/kg, 2 days) (5)

13. 77 +
- 3. 52 c

0.233 +
- 0.064 d

: 0. 038

aExpressed as mµMoles p-nitrophenol formed/mg microsomal protein/
30 min. (male rats 190-280 gms).
bExpressed as optical density units at 260 rnµ/mg microsomal protein/20 min.
csignificantly different from control (PCo~ 05).
dNot significantly different from control (P~. 05)·
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Table 5
In Vitro Inhibition of Microsomal Ribonuclease by
105, 000 x g Liver Supernatant Fraction of the
Phenobarbital-Treated Rat. a

Microsomes

Supernatant

Control

0.331

Phenobarbital

0.188

Control

Control

0.370

Phenobarbital

Phenobarbital

0.160

Control

Phenobarbital

0.258

Phenobarbital

Control

0.187

aone group of male (375-410 gm) rats was treated with 50 mg/kg
phenobarbital for 5 days. All animals were killed 24 hours after the
last treatment. Microsomes and supernatants used were obtained
from one control and one Pb-treated rat.
· bExpressed as optical density units at 260 mµ/20 min/mg microsomal protein.
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Table 6
Ribonuclease Inhibition in the Presence of P-Chloromercuribenzoate by 105, 000 x g Supernatant Fraction
Prepared from Livers of Phenobarbital-Treateda Rats.

Microsomes

b

b
Supernatant

PCMBc

Ribonuclea se

Control

0.151

Phenobarbital

o. 057

Control

+

0.120

Phenobarbital

+

0.016

Control

Control

Control

Control

Phenobarbital

Phenobarbital

Phenobarbital

Phenobarbital

Control

Phenobarbital

Control

Phenobarbital

Phenobarbital

Control

Phenobarbital

Control

e

0.231

+

0.144
0.123

+

0.164
0.031

+

0.072
0.159

+

0.139

aFour male (375-410 gm) rats were treated with 50 mg/kg phenobarbital. for
5 days. Controls were given distilled water. All animals were killed 24
hours after the last treatment.

~icrosomes and supernatants used were pooled from liver fractions prepared from at least four animals.
-6
cp-Chloromercuribenzoate (10 molar).

~ean of duplicate determinations (Optical Density 260
somal protein).

.
mµ, /2 0 min/mg micro-
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4
6
1 x 10- molar and dibutryl cyclic amp _1 x 10- molar did not alter RNase
activity when added to the incubation medium.
In order to isolate the inhibitor material, 105, 000 x g supernatant
fractions prepared from Pb-trea ted and control rat livers were fractionated
by 1Sephadex 1 column chromatography. Prior to column fractionation both
preparations contained negligible activity. In both preparations, fractions
eluted at void volumes of the' Sephadex' column were found to contain RNase
activity, while fractions eluted after void volume possessed RNase inhibitor
activity.

However, no differences in the elution profiles or in RNase activity

stimulation or inhibition was observed between the two preparations. These
results suggested that the RNase inhibitor in preparations from Pb-treated
rats was inactivated or bound to the 'Sephadex' gel.
Amphetamine Inhibition of P-Chloro-N-Methylaniline (PCMA) Demethylation.
In order to determine the effect of d-amphetamine on PCMA demethylation,

parallel incubations were carried out in the presence and absence of 3 x 10 molar d-a.mphetamine sulfate.

3

Data plotted in Figure 1 indicate that d-amphet-

amine sulfate inhibits PCMA demethylation competitively in liver preparations
from 'male and female rats. Kinetic constants presented in Table 1 indicate
that the apparent Km for PCMA demethylase activity of female rat liver is
approximately 2 times that for male liver. Conversely, the maximum velocity
of the female preparation is approximately two-thirds the corresponding value
for the male rat liver enzyme. D-amphetamine sulfate increased the apparent
Km of both preparations two-fold, while V
is virtually unchanged. Inmax
hibition constants for the two preparations are similar i.e., 2. 5 and 2. 7xlo-\.rolar
for the male and female rat liver preparations

respectiv~ly.

3
Amphetamine inhibited PCMA demethylation when 8 x 10- molar NADPH
was substituted for the NADPH-generating system. No differences in apparent
p-chloroaniline formation by boiled supernatants were observed in the presence
or absence of amphetamine in the incubation mixture.

These results suggested
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that amphetamine inhibition was not due to either interference with the
NADPH-generating system or development of color.
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Fig. 2.

z
w

Lineweaver-Burk plot of p-chloro-N-methylaniline demethylation by male and female rat liver 9000 x g supernatant in the
presence and absence of 3 mMolar d-amphetamine sulfate.
PCMA = p-chloro-N-methylaniline; PCA . = p-chloroaniline.
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Table 7
Kinetic constants for D-Amphetamine Sulfate Inhibition of
P-Chloro-N-Methylaniline Demethylation by Rat Liver
9000 x g Supernatant Fractions.
Apparent
Kinetic Constants

Control

Amphetamine

Adult Male Preparation

a

0.25

o. 54

vmaxb

2.5

2.4

K

m

Kc
1

2.5

Adult Female Preparation

a

0.49

1. 0

vmaxb

1. 7

1. 8

K

m

Kc
1

2.7

aExpressed as mMolar p-chloro-N-methylaniline concentration.
hExpressed as mµMoles p-chloroaniline formed/min/mg protein.
cExpressed as mMolar d-amphetamine sulfate concentration.
dKinetic constants were calculated from slope and intercepts determined
according to the method of least squares.

DISCUSSION
Inhibition of Microsom al Ribonuclease During Phenobarbital Induction.
Previous investigations have reported that Pb induction of DME is
associate d with increased liver protein and enhancement of RNA synthesis.
These findings are con.sistent with the observed suppression of RNase activity
by microsomal preparations from Pb-treated rats.

Conversely, three-fold

stimulation of DME by MC treatment does not significantly reduce microsomal
RNase. The findings reported here are consistent with earlier published
data which suggest that Pb and MC induce DME through different mechanisms.
The suppression of microsomal RNase reported here, when combined
with previously documented enhanced activity of nuclear RNA polymerase,
provide a mechanism to explain the increased amount of microsomal RNA,
protein (Orrenius et al. , 196 5) decreased breakdown of microsomal RNA
(Mycek and Nemeth, 1967; Mycek, In Press),

prolongation of ribosomal

RNA half-life following Pb treatment (Steele, 1970) as well as the increased
capacity for protein synthesis which occur in livers of Pb-treated rats (Kato
et al., 1966).
Inhibition of RNase activity in hypophysectomized, and adrenalectomized
rats during induction of DME by Pb indicates that intact adrenals or pituitary
glands are not required for RNase inhibition by Pb.

However, these data do

not exclude the involvement of these glands in the Pb inhibition of RNase of
intact animals. Ribonuclease inhibition was not as extensive in hypophysectomized or adrenalectomized rats . with the least inhibition of RNase following
Pb treatment observed in adrenalectomized rats.

These findings are consistent

with the suggestion of Orrenius ~ ~·, (1969) that

steroi~

hormones may be

involved in the maintenance of inducibility of rat liver DME.
RNase inhibition appears to result from increased levels of a RNase
inhibitor in cell sar> obtained from livers of Pb-treated rats.

Inhibition is

not due to a direct effe ct of Pb on RNase since addition of Pb does not result
in RNase

inhibition in vitro (Louis-Ferdinand and Fuller, 1970). These
38
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results are in agreement with those of Mycek (Biochem. Pharmacol. In Press)
who was not able to observe inhibition of microsomal nucleic acid degradation
following direct addition of Pb to the incubation mixture.
RNase inhibition does not appear to be attributable to the inhibitor
described by Shortman (1962).

He reported that the rat liver RNase inhibitor
6
was completely inactivated in the presence of 10- molar p-chloromercuribenzoate.
As a result of the inactivation of RNase inhibitor, latent RNase was activated.
Mycek (Biochem. Pharmacol. In Press) reported that PCMB concentrations in
3
excess of 10 - molar stimulated breakdown of endogenous microsomal nucleic
acid in preparations from control and Pb-treated rats. However, microsomal
RNA breakdown in preparations from Pb-treated rats following in vitro addition
of PCMB was still less than control values.
Inhibition of RNase may play a dominant role in the induction by Pb of
DME in hypophysectomized animals, since no stimulation of RNA polymerase
activity is observed in nuclei of Pb-treated rats (Nebert and Gelboin, 1969;
Wilson et al., 1967). Inhibition of RNA degradation may account for the enhancement of microsomal amino acid incorporating activity (Jondorf ~al.,
1966) and stimulation of drug metabolism observed in hypophysectomized
rats (Conney, 1961) following administration of Pb.
Inhibition of RNase might be attributed to dilution of RNase activity resulting from increases in non-RNase liver microsomal protein. However, this
is not likely since microsomal protein content is increased only 1. 5 fold
after induction with 5 doses of Pb (100 mg/kg) (Orrenius et al., 1965).
Greater increases (viz. 5-times) in microsomal protein would conceivably
be required for dilution to account for the RNase
served 24 hours following a single dose of Pb.

inhibiti~n

which was ob-

It is difficult to demonstrate

significant increases in microsomal protein 24 hours after a single dose of Pb.
Since microsomal protein is increased only 1. 5 fold, dilution would account
for only a 33 percent inhibition of RNase rendering it unlikely that the RNase
inhibition observed in these studies can be attributed to dilution of RNase
specific activity by microsomal protein.
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Competitive Inhibition

~

D-Amphetamine o.f Oxidative Demethylation.

D-Amphetamine sulfate competitively inhibited PCMA demethylation
by hepatic 9000 x g supernatant fractions prepared from male and female
rats. This finding confirms and extends earlier observations (Lal et al.,
1970) concerning amphetamine inhibition of hexobarbital oxidase activity.

Major sex differences in sensitivity to amphetamine inhibition of DME were not
apparent since the amphetamine inhibition constants for the two preparations
were similar. This inhibition did not appear to be attributable to interference
by amphetamine with NADPH-generation since inhibition was obtained when
NADPH was added directly in place of the generating system. Comparison of
control male and female rat liver PCMA demethylase kinetic constants (Table 7)
indicated that PCMA demethylation proceeded at a higher maximum velocity in
preparations from male rats . Apparent sex Wfferences in substrate dependence
of PCMA demethylase are reflected by the respective Km values (male (0. 25)
female (0. 49 mMolar) PCMA). Shenkman

et~·,

differences in hexobarbital oxidase activity.

(1967) have reported similar sex

The data indicate that sex differ-

ences in apparent PCMA demethylase maximal velocities are approximately
half those observed with hexobarbital oxidase.
As mentioned earlier, it has been reported that alternate substrates
of microsomal drug metabolizing enzymes can competitively inhibit the metabolism
of one ru1other. Since d-amphetamine is hydroxylated in vivo the competitive
inhibition of PCMA demethylation reported here may be attributed to competition
by amphetamine as an alternate substrate. This does not appear to be the
situation since it has been reported that neither microsomal preparations
(Groppetti and Costa, 1969) nor 10, 000 x g rat liver

sup~rnatants

(Dingle and

Bass, 1969) metabolize cl-amphetamine to any appreciable extent. However,
the data do not exclude the possibility that amphetamine may otherwise interact
with microsomal drug metabolism.
Amphetamine inhibition of hexobarbital oxidase is observed at inhibitor
concentrations similar to those used in this investigation.

The apparent
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amphetamine inhibition constant calculated from the data of Lal et al., (1970)
3
viz. 4 x 10- Molar is .similar to the amphetamine inhibition constant determined
3
in PCMA demethylase studies (viz. 2. 5-2. 7 x 10- Molar). Other amphetamine
derivatives inhibit hepatic oxidative demethylation. P-Chloroamphatamine
-3
-3
(Ki; 0. 4 x 10 Molar) p-hydroxyamphetamine (Ki; 24 x 10 Molar) and
3
methamphetamine (Ki; 61 x 10- Molar) inhibit PCMA demethylation by male
rat liver 9000 x g supernatant fractions (Louis- Ferdinand~ al. , 19 70).
Methylphenidate, a related phenethylamine derivative, inhibits imipramine
metabolism in mouse and rat liver. Inhibition by methylphenidate has been
reported at concentrations similar to those at which amphetamine and amphetamine derivatives inhibit PCMA demethylase. Similar inhibition constants
for imipramine metabolism, hexobarbital oxidase, or PCMA demethylase may
be attributable to an interaction by phenethyla,mine derivatives with a common
component of these enzyme systems.
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CONCLUSIONS AND SUMMARY
1)

Phenobarbital induction of rat liver microsomal drug metabolism is
associated with a dose-related inhibition of ribonuclease activity of
microsomal fractions isolated from these animals, which is not
attributable to differential lysosomal contamination between preparations from control and Pb-treated animals.

2)

Phenobarbital inhibition of RNase does not require the presence of an
intact pituitary-adrenal axis nor is the presence of either gland required for the inhibition of RNase by Pb. The data do not exclude
the· possibility that the presence of these glands enhances the
response of intact rats to inducing doses of phenobarbital.

3)

Maximal suppression of Liver Microsomal Ribonuclease Activity is
an early occurrence during induction of drug-metabolizing enzymes.
Significant reduction of ribonuclease occurs prior to a significant
increase in p-chloro-N-methylaniline demethylase activity. An
inverse relationship exists between PCMA demethylase activity and
ribonuclease during Pb induction.

4)

Induction of p-nitroanisole demethylation during treatment with 3methylcholanthrene does not result in a significant (P >o. 05) inhibition
of microsomal ribonuclease activity.

5)

Inhibition of ribonuclease is associated ·w ith the presence of a heat-stable
inhibitor in the cell sap obtained from livers of phenobarbital-treated rats.

6)

Inhibition of ribonuclease during phenobarbital

indt~ction

is not attribut-

able to a direct effect of phenobarbital on ribonuclease since addition of
phenobarbital to the incubation medium does not influence RNase activity.
7)

D-Amphetamine sulfate competitively inhibits p-chloro-N-methylaniline
demethylation by 9000 x g supernatant fractions rrepared from both male
and female rat livers.
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8)

These findings are consistent with and support the hypothesis that
inhibition of RNA degradation occurs during induction of drug
metabolizing enzymes by phenobarbital.

It is proposed that this

constitutes a major mechanism by which this drug increases liver
RNA, and enhances protein synthesis and thereby stimulates the
synthesis of drug metabolizing enzymes. The data provide evidence
for the concept that the altered degradation of RNA is a drug-vulnerable
metabolic control mechanism.

IV. RESULTS

Inhibition of Ribonuclease During

Induc~ion

!:?_y Phenobarbital.

Male rats (weighing 400-550 gms) were treated daily with Pb for
6 days and sacrificed 24 hours or 72 hours after the last Pb administration.

When rats were sacrificed 24 hours after the last Pb treatment (100 mg/kg)
aminopyrine demethylase activity was increased five-fold and the RNase
activity associated with rat liver microsomes was reduced to 1 to 2% of
control values (Table 1). When rats were sacrificed 72 hours after termination of Pb treatment, the magnitude of the total change was not as great as
observed at 24 hours. Although neither of these values were significantly
different from the 24 hours values, the RNase appeared to increase while
aminopyrine demethylase decreased toward control values. When this
experiment was repeated with microsomes of rats sacrificed 1 day following
5 daily treatments of Pb at a reduced daily dose of 50 mg/kg stimulation of
aminopyrine demethylase was again associated with a significant (P _ O. 05)
reduction of RNase.
In order to further characterize the suppression of RNase during

Phenobarbital induction, one dose (100 mg/kg) of Phenobarbital was given
to 20 male (250-300 gm) rats. Animals were killed at 24 hours intervals for
5 days. Administration of one dose of Pb (100 mg/kg) to male rats resulted in
a significant

(P~.

05) enha.Ilcement of microsomal oxidative demethylation of

PCMA after 48 hours which persisted for 4 days (Fig.1). Twenty-four hours
after Pb treatment, RNase activity of microsomal fractions was reduced to
the lowest point ~bserved, approximately 20% of control values. Microsomal
RNase was significantly depressed from control for 4 days.
As

ment~oned

earlier RNase activity has been

repo~ted

response to treatment with cortisone or growth hormone.

to change in

Therefore, the

following experiment was designed to determine whether intact pituitary or
adre.n al glands were required for the observed effects of Pb on RNase activity.
Phenobarbital (50 mg/kg or 2 5 mg/kg twice daily for 4 days)was administered
to intact, adrenalectomized or hypophysectomized maie rats. Distilled water
24

25

Table 1
Inhibition of Hepatic Ribonuclease During Induction
of Microsoma l Aminopyrine Demethylase by
Phenobarbital
Table la
Influence of Phenobarbital (100 mg/kg) Administration

a

Group (N)

Ribonucleaseb
Mean +
_ S. E.

Percent
of
Control

Aminopyrine
Demethylase
Mean:: S.E.

Control (4)

0.131 ~

100

+
17.7_1.7

100

Killed on
Day 7 (3)

0.00 4+
- 0.002 d

1. 3

93.4:10,9d

527.

Killed on
Day 9 (3)

o. 018 ~ o. 015d

5.8

+
d
72. 2 - 7. 6

408.

o. 056

Percent
of
Control

Table lb
e
Influence of Phenobarbital (50 mg/kg) Administration

Group (N)

Ribonuclease
Mean: S. E.

Control (5)

o. 357

~

Phenobarbital
0.197 :
Treated (4)

b

o. 039
o. 007f

Percent
of
Control

Aminopyrine
Demethylase
Mean_+ S. E.

Percent
of
Control

100

+
8.7_3.2

100

+
f .
78.6 - 10.6

904

55

aTwo groups of male (400-550 gm) rats were treated with 100 mg/kg
phenobarbital for 6 days. Controls received distilled water.
bExpressed .as optical density units at 26 0 mµ/mg microsom·a1 protein/2 0 min.
cExpressed as mµMoles formaldehyde formed/mg microsomal protein/hr.
dSignificantly

diff~rent (P~0.05)

from control, but not from each other (P::;.0.05).

eOne group of male (375-410 gm)rats was treated ·with 50 mg/kg phenobarbital
for 5 days. Controls received distilled water. All animals were killed 24
hours after the last treatment.
fSignificantly different (P ~ 0. 05) from control.
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Fig. 1

Effecta of Phenobarbitalb on Rat Hepatic Ribonuclease During
Stimulation of Microsomal Oxidative Demethylation .
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